Human Laboratory Study of Varenicline for Alcohol Use Disorder

Summary

This study is a double-blind, randomized, placebo-controlled, parallel group, two-site study designed to assess the effects of varenicline as compared with placebo on responses to in vivo alcohol cue exposure in the human laboratory setting.

Timeline

Start

2017-05-01

Primary completion

2018-07-01

Completion

2018-07-07

Drugs

Indications